Mark C Wiggins - Net Worth and Insider Trading
Mark C Wiggins Net Worth
The estimated net worth of Mark C Wiggins is at least $5 Million dollars as of 2024-04-30. Mark C Wiggins is the EVP Corp. and Bus. Dev. of Biogen Inc and owns about 22,780 shares of Biogen Inc (BIIB) stock worth over $5 Million. Mark C Wiggins is the Director of Zogenix Inc and owns about 2,500 shares of Zogenix Inc (ZGNX) stock worth over $66,700. Mark C Wiggins is also the Chief Business Officer of TRACON Pharmaceuticals Inc and owns about 685 shares of TRACON Pharmaceuticals Inc (TCON) stock worth over $1,284. Details can be seen in Mark C Wiggins's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Mark C Wiggins has not made any transactions after 2020-12-29 and currently still holds the listed stock(s).
Transaction Summary of Mark C Wiggins
Mark C Wiggins Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mark C Wiggins owns 3 companies in total, including TRACON Pharmaceuticals Inc (TCON) , Zogenix Inc (ZGNX) , and Biogen Inc (BIIB) .
Click here to see the complete history of Mark C Wiggins’s form 4 insider trades.
Insider Ownership Summary of Mark C Wiggins
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TCON | TRACON Pharmaceuticals Inc | 2020-12-29 | Chief Business Officer |
| ZGNX | Zogenix Inc | 2020-05-29 | director |
| BIIB | Biogen Inc | 2008-09-26 | EVP Corp. and Bus. Dev. |
Mark C Wiggins Latest Holdings Summary
Mark C Wiggins currently owns a total of 3 stocks. Among these stocks, Mark C Wiggins owns 22,780 shares of Biogen Inc (BIIB) as of September 26, 2008, with a value of $5 Million and a weighting of 98.63%. Mark C Wiggins owns 2,500 shares of Zogenix Inc (ZGNX) as of March 23, 2020, with a value of $66,700 and a weighting of 1.34%. Mark C Wiggins also owns 685 shares of TRACON Pharmaceuticals Inc (TCON) as of December 29, 2020, with a value of $1,284 and a weighting of 0.03%.
Latest Holdings of Mark C Wiggins
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BIIB | Biogen Inc | 2008-09-26 | 22,780 | 215.50 | 4,909,090 |
| ZGNX | Zogenix Inc | 2020-03-23 | 2,500 | 26.68 | 66,700 |
| TCON | TRACON Pharmaceuticals Inc | 2020-12-29 | 685 | 1.87 | 1,284 |
Holding Weightings of Mark C Wiggins
Mark C Wiggins Form 4 Trading Tracker
According to the SEC Form 4 filings, Mark C Wiggins has made a total of 0 transactions in Biogen Inc (BIIB) over the past 5 years. The most-recent trade in Biogen Inc is the sale of 734 shares on September 26, 2008, which brought Mark C Wiggins around $36,700.
According to the SEC Form 4 filings, Mark C Wiggins has made a total of 2 transactions in Zogenix Inc (ZGNX) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in Zogenix Inc is the acquisition of 2,500 shares on March 23, 2020, which cost Mark C Wiggins around $51,200.
According to the SEC Form 4 filings, Mark C Wiggins has made a total of 3 transactions in TRACON Pharmaceuticals Inc (TCON) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in TRACON Pharmaceuticals Inc is the acquisition of 50 shares on December 29, 2020, which cost Mark C Wiggins around $10,570.
Insider Trading History of Mark C Wiggins
- 1
Mark C Wiggins Trading Performance
GuruFocus tracks the stock performance after each of Mark C Wiggins's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mark C Wiggins is 11.45%. GuruFocus also compares Mark C Wiggins's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mark C Wiggins within 3 months outperforms 1 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Mark C Wiggins's insider trading performs compared to the benchmark.
Performance of Mark C Wiggins
Average Return
13.49%
Outperforming Transactions
25%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 8.5 | 11.45 | 3.01 | 13.49 | -40.86 | -54.49 |
| Relative Return to S&P 500(%) | 1.2 | 1.33 | -15.47 | -24.62 | -49.87 | -62.89 |
Mark C Wiggins Ownership Network
Ownership Network List of Mark C Wiggins
Ownership Network Relation of Mark C Wiggins
Mark C Wiggins Owned Company Details
What does TRACON Pharmaceuticals Inc do?
Who are the key executives at TRACON Pharmaceuticals Inc?
Mark C Wiggins is the Chief Business Officer of TRACON Pharmaceuticals Inc. Other key executives at TRACON Pharmaceuticals Inc include 10 percent owner Opaleye Management Inc. , director & President and CEO Charles Theuer , and Chief Operating Officer Bonne J. Adams .
TRACON Pharmaceuticals Inc (TCON) Insider Trades Summary
Over the past 18 months, Mark C Wiggins made no insider transaction in TRACON Pharmaceuticals Inc (TCON). Other recent insider transactions involving TRACON Pharmaceuticals Inc (TCON) include a net purchase of 114,899 shares made by Charles Theuer , a net sale of 4,423,539 shares made by Opaleye Management Inc. , and a net purchase of 3,500 shares made by Scott B. Brown .
In summary, during the past 3 months, insiders sold 0 shares of TRACON Pharmaceuticals Inc (TCON) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 238,283 shares of TRACON Pharmaceuticals Inc (TCON) were sold and 23,020 shares were bought by its insiders, resulting in a net sale of 215,263 shares.
TRACON Pharmaceuticals Inc (TCON)'s detailed insider trading history can be found in Insider Trading Tracker table.
TRACON Pharmaceuticals Inc Insider Transactions
Mark C Wiggins Mailing Address
Above is the net worth, insider trading, and ownership report for Mark C Wiggins. You might contact Mark C Wiggins via mailing address: 12671 High Bluff Drive Suite 200, San Diego Ca 92130.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
